UNSPSC 51281517: Fenamisal

This classification denotes an antitubercular agent with the molecular formula C13H11NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 52936SIP7V, chemically known as salicylic acid, 4-amino-, phenyl ester (8ci) but more generally known as fenamisal, which bears US NIH Compound Identifier 8609. European Medicines Agency schedules Fenamisal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07538MIG. The term FENAMISAL is an International Non-Proprietary Name.

FENAMISAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C(=O)C1C(O)CC(N)CC1)C1CCCCC1.

UNSPSC 51281517 Fenamisal, a Commodity code, does not see recent purchasing activity aligned with its nominal scope. The most-recent-state-local-contract-opportunities block contains two records: an Illinois Department of Public Health piggyback pharmaceutical contract awarded to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride (antibiotic tablets unrelated to fenamisal), and a Seminole County, Florida IFB for Naloxone and Drug Deactivation Systems (also unrelated to the code's stated product). Both opportunities were tagged to this UNSPSC code despite addressing different pharmaceutical products entirely. The source provides no evidence of state or local solicitation or award activity for fenamisal itself.

Without recent relevant opportunities, no meaningful characterization of issuing-body mix, geographic spread, or representative work is possible. Procurement professionals evaluating this code should verify the UNSPSC classification used by their target jurisdictions, as the code's current tagging appears inconsistent with actual buying patterns in state and local markets.